Immunopathogenesis of HIV infection - PubMed (original) (raw)
Review
Immunopathogenesis of HIV infection
G Pantaleo et al. Annu Rev Microbiol. 1996.
Abstract
The rate of progression of HIV disease may be substantially different among HIV-infected individuals. Following infection of the host with any virus, the delicate balance between virus replication and the immune response to the virus determines both the outcome of the infection, i.e. the persistence versus elimination of the virus, and the different rates of progression. During primary HIV infection, a burst of viremia occurs that disseminates virus to the lymphoid organs. A potent immune response ensues that substantially, but usually not completely, curtails virus replication. This inability of the immune system to completely eliminate the virus leads to establishment of chronic, persistent infection that over time leads to profound immunosuppression. The potential mechanisms of virus escape from an otherwise effective immune response have been investigated. Clonal deletion of HIV-specific cytotoxic T-cell clones and sequestration of virus-specific cytotoxic cells away from the major site of virus replication represent important mechanisms of virus escape from the immune response that favor persistence of HIV. Qualitative differences in the primary immune response to HIV (i.e. mobilization of a restricted versus broader T-cell receptor repertoire) are associated with different rates of disease progression. Therefore, the initial interaction between the virus and immune system of the host is critical for the subsequent clinical outcome.
Similar articles
- New concepts in the immunopathogenesis of HIV infection.
Pantaleo G, Fauci AS. Pantaleo G, et al. Annu Rev Immunol. 1995;13:487-512. doi: 10.1146/annurev.iy.13.040195.002415. Annu Rev Immunol. 1995. PMID: 7612232 Review. - Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.
Kilby JM. Kilby JM. Clin Infect Dis. 2001 Sep 15;33(6):873-84. doi: 10.1086/322647. Epub 2001 Aug 6. Clin Infect Dis. 2001. PMID: 11512093 Review. - The role of lymphoid organs in the pathogenesis of HIV infection.
Pantaleo G, Graziosi C, Fauci AS. Pantaleo G, et al. Semin Immunol. 1993 Jun;5(3):157-63. doi: 10.1006/smim.1993.1019. Semin Immunol. 1993. PMID: 8102261 Review. - Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.
Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher MB, Cohen OJ, Denis F, Biddison WE, Sekaly RP, Fauci AS. Pantaleo G, et al. Eur J Immunol. 1997 Dec;27(12):3166-73. doi: 10.1002/eji.1830271213. Eur J Immunol. 1997. PMID: 9464802 - New mechanisms of viral persistence in primary human immunodeficiency virus (HIV) infection.
Soudeyns H, Pantaleo G. Soudeyns H, et al. J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):37-9. J Biol Regul Homeost Agents. 1997. PMID: 9418159 Review.
Cited by
- STING and cGAS gene expressions were downregulated among HIV-1-infected persons after antiretroviral therapy.
de Lima LLP, de Oliveira AQT, Moura TCF, da Silva Graça Amoras E, Lima SS, da Silva ANMR, Queiroz MAF, Cayres-Vallinoto IMV, Ishak R, Vallinoto ACR. de Lima LLP, et al. Virol J. 2021 Apr 15;18(1):78. doi: 10.1186/s12985-021-01548-6. Virol J. 2021. PMID: 33858455 Free PMC article. - Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue.
Grivel JC, Malkevitch N, Margolis L. Grivel JC, et al. J Virol. 2000 Sep;74(17):8077-84. doi: 10.1128/jvi.74.17.8077-8084.2000. J Virol. 2000. PMID: 10933717 Free PMC article. - Virus phenotype switching and disease progression in HIV-1 infection.
Callaway DS, Ribeiro RM, Nowak MA. Callaway DS, et al. Proc Biol Sci. 1999 Dec 22;266(1437):2523-30. doi: 10.1098/rspb.1999.0955. Proc Biol Sci. 1999. PMID: 10693824 Free PMC article. - Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial.
Ashenafi S, Amogne W, Kassa E, Gebreselassie N, Bekele A, Aseffa G, Getachew M, Aseffa A, Worku A, Hammar U, Bergman P, Aderaye G, Andersson J, Brighenti S. Ashenafi S, et al. Nutrients. 2019 Jan 10;11(1):133. doi: 10.3390/nu11010133. Nutrients. 2019. PMID: 30634590 Free PMC article. Clinical Trial. - Immunogenetics: Genome-Wide Association of Non-Progressive HIV and Viral Load Control: HLA Genes and Beyond.
Limou S, Zagury JF. Limou S, et al. Front Immunol. 2013 May 27;4:118. doi: 10.3389/fimmu.2013.00118. eCollection 2013. Front Immunol. 2013. PMID: 23750159 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical